B-Cell Non-Hodgkin Lymphoma — Trials

B-Cell Non-Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

6,180 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,757
Recruiting: 906
Ph III recruiting: 103
Growth YoY: +6.8%
Industry share: 27%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (954)

clinicaltrialsPublishedShowing 2,951–2,959 of 2,959 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00180895	Rituximab in Children and Adolescents With Relapsed and Refractory B-Cell NHL/L3ALL	terminated	Phase 2	40	Gustave Roussy, Cancer Campus, Grand ParisOTHER	1	Sep 11, 2006	clinicaltrials
NCT00337506	Velcade Combined With High-Dose Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma	terminated	Phase 2	50	Nantes University HospitalOTHER	1	Jun 16, 2006	clinicaltrials